Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.98 SEK | +1.35% | -0.66% | +7.54% |
05-16 | Polygiene Group AB Resolves Board Changes | CI |
04-25 | Polygiene Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 55% by 2026.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company appears to be poorly valued given its net asset value.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the past twelve months, EPS forecast has been revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- Low profitability weakens the company.
- The company is highly valued given the cash flows generated by its activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.54% | 31.34M | D+ | ||
+22.96% | 69.65B | A- | ||
-4.86% | 46.9B | A- | ||
+30.76% | 27.98B | A- | ||
+9.47% | 19.58B | C+ | ||
+14.46% | 17.08B | B+ | ||
-11.15% | 15.08B | B+ | ||
-27.44% | 14.52B | A- | ||
-32.93% | 11.54B | A- | ||
-35.08% | 11.02B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- POLYG Stock
- Ratings Polygiene Group AB